Definitive Healthcare Corp. (NASDAQ:DH) Short Interest Update

Definitive Healthcare Corp. (NASDAQ:DH) was the recipient of a significant increase in short interest during the month of February. As of February 28th, there was short interest totalling 2,770,000 shares, an increase of 30.0% from the February 13th total of 2,130,000 shares. Currently, 6.8% of the shares of the company are short sold. Based on an average daily trading volume, of 823,600 shares, the days-to-cover ratio is currently 3.4 days.

Hedge Funds Weigh In On Definitive Healthcare

Institutional investors have recently modified their holdings of the company. Massachusetts Financial Services Co. MA raised its holdings in Definitive Healthcare by 36.8% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock valued at $27,058,000 after acquiring an additional 1,626,813 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. purchased a new position in Definitive Healthcare during the third quarter worth about $512,000. Hennion & Walsh Asset Management Inc. boosted its stake in Definitive Healthcare by 34.1% in the 4th quarter. Hennion & Walsh Asset Management Inc. now owns 50,886 shares of the company’s stock worth $209,000 after buying an additional 12,946 shares during the last quarter. Barclays PLC grew its holdings in Definitive Healthcare by 318.8% in the 3rd quarter. Barclays PLC now owns 81,916 shares of the company’s stock valued at $366,000 after buying an additional 62,354 shares during the period. Finally, JPMorgan Chase & Co. increased its stake in shares of Definitive Healthcare by 431.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 222,090 shares of the company’s stock valued at $993,000 after acquiring an additional 180,323 shares during the last quarter. Institutional investors and hedge funds own 98.67% of the company’s stock.

Analyst Upgrades and Downgrades

DH has been the subject of several analyst reports. Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a research note on Thursday, January 16th. The Goldman Sachs Group dropped their price objective on shares of Definitive Healthcare from $4.50 to $3.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 4th. Stephens began coverage on shares of Definitive Healthcare in a research note on Friday, December 20th. They issued an “equal weight” rating and a $5.00 target price for the company. Finally, Barclays dropped their price target on shares of Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating on the stock in a research note on Monday, March 3rd. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $5.35.

Definitive Healthcare Price Performance

NASDAQ:DH traded up $0.11 during trading hours on Tuesday, reaching $2.78. 878,514 shares of the company traded hands, compared to its average volume of 746,671. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.49 and a quick ratio of 2.49. The firm’s 50-day moving average is $4.31 and its 200-day moving average is $4.36. The stock has a market cap of $313.33 million, a P/E ratio of -0.90, a P/E/G ratio of 4.06 and a beta of 1.51. Definitive Healthcare has a 1-year low of $2.55 and a 1-year high of $8.35.

Definitive Healthcare (NASDAQ:DH) last posted its quarterly earnings data on Thursday, February 27th. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.04). Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. The company had revenue of $62.29 million for the quarter, compared to analyst estimates of $60.60 million. Equities research analysts expect that Definitive Healthcare will post 0.16 earnings per share for the current fiscal year.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.